![一种中药提取物的组合物在制备促进卵巢颗粒细胞增殖药物中的用途](/CN/2019/1/131/images/201910655776.jpg)
基本信息:
- 专利标题: 一种中药提取物的组合物在制备促进卵巢颗粒细胞增殖药物中的用途
- 专利标题(英):Application of composition of traditional Chinese medicine extract in preparing drug for promoting proliferation of ovarian granular cells
- 申请号:CN201910655776.X 申请日:2019-07-19
- 公开(公告)号:CN110279733A 公开(公告)日:2019-09-27
- 发明人: 宋萍萍 , 毛艳 , 韦敏 , 姜晓雁 , 吕晔 , 颜露 , 钱怡云
- 申请人: 江苏省中国科学院植物研究所 , 湖南省很美健康科技有限责任公司
- 申请人地址: 江苏省南京市溧水县白马镇国家农业科技园植物所基地
- 专利权人: 江苏省中国科学院植物研究所,湖南省很美健康科技有限责任公司
- 当前专利权人: 江苏省中国科学院植物研究所,湖南省很美健康科技有限责任公司
- 当前专利权人地址: 江苏省南京市溧水县白马镇国家农业科技园植物所基地
- 主分类号: A61K36/23
- IPC分类号: A61K36/23 ; A61P15/08
The invention discloses a novel application of a composition of mistletoe and centella extract in preparing a drug for promoting proliferation of ovarian granular cells to further adjust ovarian dysfunction. According to traditional Chinese medicine theory and pathogenesis of ovarian dysfunction and hypotrophy of ovarian granular cells, the novel application of combining composition of mistletoe and centella extract in treating ovarian dysfunction and promoting proliferation of ovarian granular cells is developed through a lot of pharmacology experiments by making full use of traditional Chinese medicine resources, and the weight proportion of mistletoe and centella in the composition of the mistletoe and centella extract with the highest activity is screened through a lot of experiments. Compared with single use of mistletoe extract and centella extract, the mistletoe extract and centella extract are combined to play a better role to proliferation of ovarian granular cells and have higher activity to adjust ovarian dysfunction. The mistletoe extract and centella extract have a synergistic effect. A product prepared by combining the mistletoe extract and centella extract to treat ovarian dysfunction and promote proliferation of ovarian granular cells has the advantages of being good in curative effect, small in side effect, convenient to use and the like.
公开/授权文献:
- CN110279733B 一种中药提取物的组合物在制备促进卵巢颗粒细胞增殖药物中的用途 公开/授权日:2022-05-20
IPC结构图谱:
A | 人类生活必需 |
--A61 | 医学或兽医学;卫生学 |
----A61K | 医用、牙科用或梳妆用的配制品 |
------A61K36/00 | 含有来自藻类、苔藓、真菌或植物或其派生物,例如传统草药的未确定结构的药物制剂 |
--------A61K36/18 | .被子植物亚门 |
----------A61K36/185 | ..双子叶植物纲 |
------------A61K36/23 | ...伞形科,如莳萝、细叶芹、芫荽或土茴香 |